S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

MNPR Monopar Therapeutics Inc

42.15

1.18 (2.88%)

Last Updated: 06:07:51

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Monopar Therapeutics (NASDAQ:MNPR)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Monopar Therapeutics Charts.

Monopar Therapeutics (NASDAQ:MNPR)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Monopar Therapeutics Charts.

Monopar Therapeutics Inc News

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Saturday 8 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 28 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics
Friday 24 January 2025 (4 weeks ago) • PR Newswire (US)

Form S-3 - Registration statement under Securities Act of 1933
Thursday 16 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 3 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 3 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 24 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Monday 23 December 2024 (2 months ago) • Edgar (US Regulatory)

Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
Saturday 21 December 2024 (2 months ago) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Thursday 19 December 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Wednesday 18 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (2 months ago) • Edgar (US Regulatory)

More Monopar Therapeutics Inc News Articles

Vanftseallworld

Societe Generale Effekten

CapitaLand Integrated Co... (PK)

ENGIE BRASIL ON

Amundi US Treasury Bond ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions